Citadel Advisors - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 103 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,415,172
+81.5%
279,833
+30.6%
0.00%0.0%
Q2 2023$3,534,335
-52.6%
214,332
-48.7%
0.00%0.0%
Q1 2023$7,456,049
+113.7%
417,940
+248.9%
0.00%
Q4 2022$3,488,518
-45.8%
119,798
-54.4%
0.00%
-100.0%
Q3 2022$6,435,000
+302.9%
262,635
-31.7%
0.00%
Q2 2022$1,597,000
-68.9%
384,758
-13.6%
0.00%
-100.0%
Q1 2022$5,129,000
+4479.5%
445,224
+3875.2%
0.00%
Q4 2021$112,000
-32.5%
11,200
-11.8%
0.00%
Q3 2021$166,000
-81.0%
12,700
-71.6%
0.00%
Q2 2021$875,000
-72.2%
44,674
-69.8%
0.00%
-100.0%
Q1 2021$3,146,000
-6.7%
147,908
+30.4%
0.00%0.0%
Q4 2020$3,372,000
+118.7%
113,446
+59.3%
0.00%
Q3 2020$1,542,000
+388.0%
71,198
+243.0%
0.00%
Q1 2020$316,000
-19.2%
20,758
+43.0%
0.00%
Q4 2018$391,000
-3.2%
14,521
+4.8%
0.00%
Q3 2018$404,000
-74.3%
13,850
-72.4%
0.00%
-100.0%
Q2 2018$1,570,000
+45.2%
50,215
-7.5%
0.00%0.0%
Q1 2018$1,081,000
-81.6%
54,299
-73.1%
0.00%
-75.0%
Q4 2017$5,866,000201,8280.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 810,000$19,845,0008.20%
NEA Management Company, LLC 4,912,306$108,316,0005.41%
Frazier Life Sciences Management, L.P. 1,894,000$46,403,0003.57%
RA Capital Management 5,471,067$134,041,0002.86%
Samsara BioCapital, LLC 345,293$8,460,0001.97%
Altium Capital Management LP 170,000$4,165,0001.53%
Parkman Healthcare Partners LLC 187,989$4,606,0001.31%
Rock Springs Capital Management LP 1,760,865$43,141,0001.11%
EAM Investors, LLC 198,699$4,868,0001.06%
Prosight Management, LP 80,000$1,960,0001.05%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders